5.49 -0.01 (-0.18%)
ISPH
Stock Details
Last Trade:5.49 Change:-0.01 (-0.18%) Prev Close:5.50 Open: 5.59 Days Range:5.46 – 5.63 52 Week Range: 2.59 - 7.03 Volume:207644 P/E: N/AEPS:-0.80
View AllRecent Alerts 02/10/10
Recent Alert on 02/08/10 at 10:50am
Piper Jaffray Names Inspire (ISPH) and Vertex Pharmaceuticals (VRTX) as Top Picks
Piper Jaffray Names Inspire (ISPH) and Vertex Pharmaceuticals (VRTX) as Top Picks
Piper Jaffray names Inspire (Nasdaq: ISPH) and Vertex Pharmaceuticals (Nasdaq: VRTX) as Top Picks. Piper analyst says, "We see Cystic Fibrosis (CF) as the next major orphan drug opportunity. Although no disease modifying agents have been... Read More
Recent Alert on 01/27/10 at 9:42am
Wedbush Maintains a 'Neutral' on Inspire Pharmaceuticals (ISPH); Lowers PT & Estimates
Wedbush Maintains a 'Neutral' on Inspire Pharmaceuticals (ISPH); Lowers PT & Estimates
Recent Alert on 01/21/10 at 1:42pm
Unusual 11 Mid-Day Movers 1/21: ISR, BOFL, HAFC, FIT, FBP Higher; APWR, ISPH, HEAT, DROOY Lower
Unusual 11 Mid-Day Movers 1/21: ISR, BOFL, HAFC, FIT, FBP Higher; APWR, ISPH, HEAT, DROOY Lower
Recent Alert on 01/21/10 at 10:58am
Morning Movers 1/21: ISR, BOFL, FIT, LPTH, HAFC, PLXS Higher; BBI, APWR, ISPH, LYTS, TSS, TONE Lower
Morning Movers 1/21: ISR, BOFL, FIT, LPTH, HAFC, PLXS Higher; BBI, APWR, ISPH, LYTS, TSS, TONE Lower
Recent Alert on 01/21/10 at 7:13am
Inspire Pharma's (ISPH) PROLACRIA Dry Eye Treatment Phase 3 Did Not Meet Endpoint
Inspire Pharma's (ISPH) PROLACRIA Dry Eye Treatment Phase 3 Did Not Meet Endpoint
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 05/29/09 at 11:30am
Analyst upgrades, downgrades and initiations: MS, JCG, BKC, LVLT, NWS ...
Analyst upgrades, downgrades and initiations: MS, JCG, BKC, LVLT, NWS ...